Imetelstat leads to durable red blood cell transfusion independence
by Elana GotkineFor heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competi
Updated on: January 26,2024
19
Imetelstat leads to durable red blood cell transfusion independence
by Elana GotkineFor heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competi
Updated on:January 26,2024
19
